Table 4 Clinical adverse effects
Overall | H101 | Control | P value | |
|---|---|---|---|---|
Fever | 0.023 | |||
> 38.5 °C | 55.4 % | 64.4 % | 46.6 % | |
≤ 38.5 °C | 44.6 % | 35.6 % | 53.4 % | |
Pain | 0.875 | |||
Yes | 65.1 % | 64.4 % | 65.9 % | |
No | 34.9 % | 35.6 % | 34.1 % | |
Ascites | 0.864 | |||
Yes | 25.7 % | 26.4 % | 25 % | |
No | 74.3 % | 73.6 % | 75 % | |
Acute renal failure | ||||
Yes | 5.1 % | 5.7 % | 4.5 % | 0.896 |
No | 94.9 % | 94.3 % | 95.5 % | |
Encephalopathy | ||||
Yes | 0 | 0 | 0 | |
No | 100 % | 100 % | 100 % | |
White Blood Cell | ||||
Before TACE | 5.7 | 6.0 | 5.5 | 0.369 |
After TACE | 7.64 | 7.0 | 8.84 | 0.991 |
Elevation | 1.61 | 0.5 | 2.97 | 0.001 |
PLT | ||||
Before | 167.0 | 179.2 | 154.5 | 0.186 |
After | 113.0 | 122.8 | 106.1 | 0.258 |
Elevation | 49.0 | 52.7 | 48.4 | 0.480 |
ALT | ||||
Before | 41.5 | 43.2 | 41.4 | 0.371 |
After | 167.1 | 153.0 | 200.9 | 0.405 |
Elevation | 103.1 | 88.1 | 118.4 | 0.480 |
AST | ||||
Before | 50.9 | 57.1 | 46.4 | 0.249 |
After | 221.3 | 225.4 | 213.5 | 0.993 |
Elevation | 154.2 | 141.2 | 162.0 | 0.863 |
TBIL | ||||
Before | 16.3 | 16.1 | 16.8 | 0.657 |
After | 30.4 | 28.3 | 31.8 | 0.162 |
Elevation | 12.9 | 12.4 | 13.25 | 0.413 |
ALB | ||||
Before | 40.0 | 38.2 | 41.2 | 0.161 |
After | 35.4 | 34.1 | 37.0 | 0.314 |
Elevation | 4.1 | 3.6 | 4.4 | 0.226 |